Pulmonary artery distensibility in pulmonary arterial hypertension: an MRI pilot study
Authors:
- C. JardimC. Jardim
- C. E. RochitteCRC. E. Rochitte
- M. HumbertM. Humbert
- G. RubenfeldGRG. Rubenfeld
- D. JasinowodolinskiDJD. Jasinowodolinski
- C. R. R. CarvalhoC. R. R. Carvalho
- R. SouzaR. Souza
- 29 November 2006
- journal article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 29 (3) , 476-481
Abstract
Pulmonary arterial hypertension (PAH) is a disease of the small vessels in which there is a substantial increase in pulmonary vascular resistance leading to right ventricle failure and death. Invasive haemodynamic evaluation is mandatory not only for diagnosis confirmation but also to address prognosis and eligibility for the use of calcium-channel blockers through an acute vasodilator challenge. Noninvasive surrogate response markers to the acute vasodilator test have been sought.In the present study, the relationship between pulmonary artery distensibility, assessed using magnetic resonance imaging (MRI), and response to acute vasodilator tests was investigated. In total, 19 patients diagnosed with idiopathic PAH without any specific treatment were evaluated. Within a 48-h window after pulmonary artery catheterisation, patients underwent cardiac MRI.Cardiac index, calculated after the determination (invasively and noninvasively) of cardiac output, showed excellent correlation, as did right atrial pressure and right ventricle ejection fraction. Pulmonary artery distensibility was significantly higher in responders. A receiver operating characteristic curve analysis has shown that 10% distensibility was able to differentiate responders from nonresponders with 100% sensitivity and 56% specificity.The present findings suggest that magnetic resonance imaging and pulmonary artery distensibility may be useful noninvasive tools for the evaluation of patients with pulmonary hypertension.Keywords
This publication has 29 references indexed in Scilit:
- Acute vasodilator test in pulmonary arterial hypertension: Evaluation of two response criteriaVascular Pharmacology, 2005
- N-terminal-pro-brain natriuretic peptide as a haemodynamic marker in idiopathic pulmonary arterial hypertensionEuropean Respiratory Journal, 2005
- Pulmonary Arterial HypertensionNew England Journal of Medicine, 2004
- Treatment of Pulmonary Arterial HypertensionNew England Journal of Medicine, 2004
- Primary pulmonary arterial hypertensionJACC, 2004
- Diagnosis and differential assessment of pulmonary arterial hypertensionJACC, 2004
- Clinical classification of pulmonary hypertensionJACC, 2004
- Ventricular mass index using magnetic resonance imaging accurately estimates pulmonary artery pressureEuropean Respiratory Journal, 2002
- Haemodynamic evaluation of pulmonary hypertensionEuropean Respiratory Journal, 2002
- Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertensionEuropean Respiratory Journal, 1998